Søgning


Flere søgeindstillinger

Søgning på udtrykket 'mycoplasma' giver 29 resultater


Dokumenter [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [8]
Dokumenter [1]

National retningslinje for håndtering af voksne patienter indlagt med pneumoni. Udarbejdet af repræsentanter for DSI, DLS og DSKM 2. udgave, 2025

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?

Infection
14.02.2025
. Abstract. . Purpose. Severe pneumonia, refractory pneumonia and extrapulmonary complications caused by mycoplasma pneumoniae infection were increasing, posing a serious threat to health. This study aimed to explore a breakthrough for further investigations in further. . . . Methods.
BMC Infectious Diseases
14.02.2025
. Abstract. . Background. Mycoplasma hominis is a part of the microflora of the urogenital tract; however, extra-urogenital infections due to M. hominis are rare. Herein, we present a case study of a patient who successfully recovered from a sternal wound infection caused by M. hominis. . . . Case presentation.
Infection
13.02.2025
. Abstract. . Purpose. Severe pneumonia, refractory pneumonia and extrapulmonary complications caused by mycoplasma pneumoniae infection were increasing, posing a serious threat to health. This study aimed to explore a breakthrough for further investigations in further. . . . Methods.
Infection
1.02.2025
. Abstract. . Background. Mycoplasma pneumoniae is a prevalent pathogen in pediatric community-acquired pneumonia. Currently, limited literature exists on the clinical utilization of pathogen-targeted sequencing technologies. . . . Methods.
Infection
31.01.2025
. Abstract. . Background. Mycoplasma pneumoniae is a prevalent pathogen in pediatric community-acquired pneumonia. Currently, limited literature exists on the clinical utilization of pathogen-targeted sequencing technologies. . . . Methods.
BMC Infectious Diseases
30.01.2025
… Abstract. . Background. The COVID-19 (SARS-CoV-2) epidemic has posed a major challenge to global public health, especially in children. Some children may experience secondary infection with Mycoplasma pneumoniae after SARS-CoV-2 infection, which has attracted widespread attention.
BMC Infectious Diseases
28.01.2025
… Abstract. . Background. The COVID-19 (SARS-CoV-2) epidemic has posed a major challenge to global public health, especially in children. Some children may experience secondary infection with Mycoplasma pneumoniae after SARS-CoV-2 infection, which has attracted widespread attention.
BMC Infectious Diseases
12.01.2025
… Abstract. . Background. Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by Dabie bandavirus (DBV). We report a case of DBV and Mycoplasma pneumoniae (MP) co-infection. . . . Case presentation.
BMC Infectious Diseases
4.01.2025
…ckground. In China many respiratory pathogens stayed low activities amid the COVID-19 pandemic due to strict measures and controls. We here aimed to study the epidemiological and clinical characteristics of pediatric inpatients with Mycoplasma pneumoniae pneumonia (MPP) after the mandatory COVID-19 restrictions were lifted, in comparison to those before the COVID-19 pandemic. . . . Methods.
Antimicrobial Agents And Chemotherapy
14.12.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
PLoS One Infectious Diseases
26.10.2024
by Huanbing Long, Guiting He, Jiarong He, Ting feng Du, Pengxiao Feng, Cuiming Zhu . Mycoplasma pneumoniae represents one of the significant etiologies of community-acquired pneumonia in pediatric patients. However, clinical treatment of M. pneumoniae infection in children has encountered challenges due to the escalating resistance to quinolones.
BMC Infectious Diseases
18.10.2024
. Abstract. . Background. Macrolide-resistant Mycoplasma pneumoniae (MRMP) strains are increasingly prevalent, leading to a rise in severe Mycoplasma pneumoniae pneumonia incidence annually, which poses a significant threat to children’s health. This study aimed to compare the effectiveness and safety of oral minocycline and doxycycline for the treatment of severe MRMP pneumonia in children. . .
BMC Infectious Diseases
17.09.2024
. Abstract. . Background. Mycoplasma genitalium (MG), a sexually transmitted infection (STI), has emerged as a common cause of non-gonococcal urethritis and cervicitis worldwide, with documented resistance to commonly used antibiotics including doxycycline and azithromycin. Data in Ghana regarding the prevalence of MG is limited. . . . Methods.
BMC Infectious Diseases
14.09.2024
. Abstract. . Background. X-linked agammaglobulinemia (XLA), also referred to as Bruton’s tyrosine kinase deficiency, is a rare genetic disorder that affects the immune system.
BMC Infectious Diseases
6.09.2024
. Abstract. . Background. The clinical significance of the presence or absence of Mycoplasma pneumoniae (MP) in pleural effusion in Mycoplasma pneumoniae pneumonia (MPP) children has not yet been elucidated. Herein, we investigated the clinical implication of pleural fluid MP positive in children with MPP. . . . Methods.
International Journal of Infectious Diseases
6.08.2024
Respiratory infections represent a significant burden on global public health, contributing to substantial morbidity and mortality worldwide. These infections encompass a spectrum of illnesses affecting the upper and lower respiratory tract, often resulting in severe complications, hospitalizations, and increased healthcare expenditure. Among the causative agents, M.
BMC Infectious Diseases
1.08.2024
. Abstract. . Background. The global prospective surveillance data showed the re-emergence of mycoplasma pneumoniae pneumonia (MPP) in Europe and Asia after the coronavirus disease 2019 pandemic.

Aktuelle smitsomme sygdomme [8]

Aktuelle smitsomme sygdomme [8]
ProMED
14.01.2025
. . . MYCOPLASMA PHOCIMORSUS - DENMARK: TENDINOUS PANARITIUM, CAT SCRATCH. *******************************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Fri 10 Jan 2025 . Source: Emerging Infectious Diseases [edited] . doi.org/10.3201/eid3102.241219 . . . Citation: Skafte-Holm A, Pedersen TR, Frølund M, et al. _Mycoplasma.
Morbidity and Mortality Weekly Report (MMWR)
20.12.2024
This report describes Mycoplasma pneumoniae infections among students and staff of a large public school district in Missouri.
Medscape Infectious Diseases
2.11.2024
Medscape Medical News spoke with the CDC's Adam L. Cohen, MD, MPH, about what healthcare providers need to know about the increased number and severity of cases in young patients in the United States. . CDC Expert Commentary
Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
ECDC Communicable Disease Threats Report
24.01.2025
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 November - 6 December2024 and includes updates on increases in respiratory infections due to Mycoplasma pnemoniae in the EU/EEA, SARS-CoV-2 variant classification, Influenza A(H5N1), Avian influenza, Middle East respiratory syndrome, an unknown disease in the Democratic Republic of the Congo, mpox, suspected viral hemorrhagic fever in Sierra Leone, and overview of respiratory virus epidemiology in the EU/EEA.
ECDC COVID-19 updates
11.01.2025
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 30 November - 6 December2024 and includes updates on increases in respiratory infections due to Mycoplasma pnemoniae in the EU/EEA, SARS-CoV-2 variant classification, Influenza A(H5N1), Avian influenza, Middle East respiratory syndrome, an unknown disease in the Democratic Republic of the Congo, mpox, suspected viral hemorrhagic fever in Sierra Leone, and overview of respiratory virus epidemiology in the EU/EEA.
Statens Serum Institut
20.12.2024
Covid-19 er på et væsentligt lavere blus end sidste år. Til gengæld er smitten med influenza og RS-virus stigende, og Mycoplasma er også på spil.
Eurosurveillance latest updates
9.08.2024
Since November 2023, the absolute number of attendances at emergency departments for pneumonia among children aged 5–14 years in England have been above expected levels for the time of year. This increased signal peaked during March 2024 but then persisted into early summer 2024 despite decreases in prevalence of seasonal respiratory pathogens. Record linkage between emergency department and laboratory databases points to this unusual activity being driven largely by Mycoplasma pneumoniae. .

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2025 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.2.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.919 s

Cookies og privatliv